Journal article icon

Journal article

A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.

Abstract:
We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred in the 10 patients.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1002/mds.870060114

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience, Biomedical Research Centre
Role:
Author
Journal:
Movement disorders : official journal of the Movement Disorder Society
Volume:
6
Issue:
1
Pages:
73-75
Publication date:
1991-01-05
DOI:
EISSN:
1531-8257
ISSN:
0885-3185
URN:
uuid:903ffc1a-40c0-40ce-a4c9-93845c280a43
Source identifiers:
369011
Local pid:
pubs:369011

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP